Regina Girones-Sarrio - Publications

Management of glioblastoma in the elderly.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 09, 2026

Climate disasters and cancer care: the Valencia DANA as a case for system resilience.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 04, 2026

Inequities in enrollment across clinical trial phases and the need for a Spanish perspective.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 24, 2025

Impact of social determinants on the development, diagnosis, and treatment of cancer: recommended public health interventions.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 31, 2025

Perceptions of social determinants influencing cancer development, outcomes, and treatment toxicity among Spanish oncologists, nurses, and pharmacists: a cross-sectional survey.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 24, 2025

Therapeutic Alliances for Optimizing the Management of Patients with Prostate Cancer: SOGUG Multidisciplinary Expert Panel Recommendations.

Journal: Cancers

Published: July 16, 2025

Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study.

Journal: Clinical genitourinary cancer

Published: April 24, 2025

Clinical and radiological features of pseudoprogression in brain tumors treated with immune checkpoint inhibitors.

Journal: Journal of neuro-oncology

Published: April 07, 2025

Pilot phase 2 study of the efficacy, safety, and tolerability of first-line cabozantinib for older fragile patients with metastatic renal cell carcinoma: The SOGUG-CABOMAYOR study.

Journal: Journal of geriatric oncology

Published: February 14, 2025

Strategies to enhance management of HER2-positive breast cancer in the elderly: an expert consensus perspective.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: September 26, 2024

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 20, 2024

Lenvatinib plus Pembrolizumab Following Immune Checkpoint Inhibitor Treatment in Patients with Metastatic Clear Cell Renal Cell Carcinoma: Results from Study 111/KEYNOTE-146.

Journal: European urology

Published: January 11, 2024